These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Evidence for the Use of Epoprostenol to Treat Raynaud's Phenomenon With or Without Digital Ulcers. Cruz JE; Ward A; Anthony S; Chang S; Bae HB; Hermes-DeSantis ER Ann Pharmacother; 2016 Dec; 50(12):1060-1067. PubMed ID: 27465880 [TBL] [Abstract][Full Text] [Related]
11. [Digital necrosis in Raynaud's phenomenon revealing a testicular seminoma. Value of prostacyclin]. Taillan B; Ferrari E; Castanet J; Campagni JP; Garnier G; Fuzibet JG; Benchimol D; Dujardin P Presse Med; 1992 Jun; 21(23):1070-1. PubMed ID: 1387938 [TBL] [Abstract][Full Text] [Related]
12. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study. Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711 [TBL] [Abstract][Full Text] [Related]
14. New prospects for the treatment of Raynaud's phenomenon using a serotoninergic S2 receptor antagonist (ketanserin) and stable derivatives of prostacyclin. Pola P; Tondi P; Serricchio M; Favuzzi A; Gerardino L Angiology; 1993 Feb; 44(2):123-8. PubMed ID: 8434805 [TBL] [Abstract][Full Text] [Related]
15. [Trial treatment of severe Raynaud's phenomenon with prostacyclin (PGI2)]. Cabane J; Boue F; Godeau P; Lecompte T; Charpentier MC; Samama M; Nebout T Rev Med Interne; 1985 Dec; 6(5):581-9. PubMed ID: 3914023 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of severe Raynaud syndrome in scleroderma or thromboangiitis obliterans with prostacyclin (prostaglandin I2)]. Rüthlein HJ; Riegger G; Auer IO Z Rheumatol; 1991; 50(1):16-20. PubMed ID: 2058317 [TBL] [Abstract][Full Text] [Related]
17. [1st intravenous administration of prostacyclin to man]. Szczeklik A; Gryglewski R; Nizankowski R; Musiał J; Serwońska M; Pietoń R; Mruk J Pol Tyg Lek; 1978 Sep; 33(36):1405-8. PubMed ID: 360190 [No Abstract] [Full Text] [Related]
18. [Treatment of Raynaud's phenomenon in scleroderma with a new stable prostacyclin derivative]. Keller J; Kaltenecker A; Schricker KT; Krais T; Schönberger A; Gevatter M; Hornstein OP Dtsch Med Wochenschr; 1984 Sep; 109(38):1433-8. PubMed ID: 6383760 [TBL] [Abstract][Full Text] [Related]
19. Acute hemodynamic effects of prostacyclin infusion in severe or malignant hypertension. Chaignon M; Tannieres-Ruffie ML; Lucsko M; Guedon J Eur Heart J; 1982 Oct; 3 Suppl C():39-43. PubMed ID: 6756922 [No Abstract] [Full Text] [Related]